Bank Of Montreal Xenon Pharmaceuticals Inc. Transaction History

Bank Of Montreal

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$42.66 - $50.04 $38,777 - $45,486	909 New	909 $39,000
Q2 2023 Aug 02, 2023	BUY	$34.84 - $43.54 $6.65 Million - $8.32 Million	191,011 New	191,011 $7.35 Million
Q4 2021 Feb 11, 2022	SELL	$15.6 - $35.4 $1.29 Million - $2.94 Million	-82,967 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$14.86 - $19.45 $62,248 - $81,476	-4,189 Reduced 4.81%	82,967 $1.25 Million
Q2 2021 Aug 12, 2021	BUY	$16.81 - $20.0 $1.47 Million - $1.74 Million	87,156 New	87,156 $1.62 Million

212

70.2M

88.3K

28.8K

Ticker XENE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,263,500
Market Cap $2.42B
Description
Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopath...

Get notified when there are updates to the investment portfolio of Bank Of Montreal , based on Form 13F filings with the SEC.

Stay updated on Bank Of Montreal with notifications on news.